Mondelez International (NASDAQ:MDLZ – Get Free Report) had its price objective reduced by Stifel Nicolaus from $82.00 to $70.00 in a research report issued to clients and investors on Friday,Benzinga ...

Good news about an experimental weight-loss shot sent shares in Ozempic maker Novo Nordisk soaring, making it once again Europe's most-valuable listed company. A pullback in the Danish drug maker's ...

There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

Stifel lowered the firm’s price target on Mondelez (MDLZ) to $70 from $82 and keeps a Buy rating on the shares. The firm, which maintains a ...

European companies are set to deliver a third straight quarter of profit growth, which may help to maintain newfound investor ...

Shares of Sandvik (ST:SAND) rose more than 3% on Thursday following a stronger-than-expected fourth-quarter results, as the company reported a 3% beat on order intake, driven primarily by strong ...

The music has stopped for Mozartkugeln, arguably Salzburg's most famous sweets. Also known as 'Mozart Balls' the dark chocolate-covered pistachio, marzipan and nougat delights will no longer be made ...

Mondelez International (NASDAQ:MDLZ – Get Free Report) was downgraded by stock analysts at Jefferies Financial Group from a ...

Barry Callebaut, the Swiss chocolate maker, has reported a decrease in sales volume for the first quarter of its 2025 fiscal ...

Predictions for 2025’s travel trends by tourism operators and booking sites have consistently highlighted the continuing ...

News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, Tax Shelters, Insurance bonds. Food for thought: Have investors lost their ...